Morningstar

Replimune (REPL) Shares Tank 45% After Company Says No Pathway Identified For Lead Drug RP1, Securities Class Action Pending - Hagens Berman

On July 22, 2025, Replimune publicly announced that the U.S. Food and Drug Administration (FDA) had issued a "Complete Response Letter" (CRL) for its Biologics License Application (BLA) for RP1. This ...
Variety

Park Chan-wook on Korea’s Cinema Crisis, ‘Unfortunate’ WGA Expulsion and the Message Behind Busan Opener ‘No Other Choice’: ‘Is It All Meaningless?’

Park Chan-wook is witnessing a crisis in Korean cinema firsthand. Korean cinema is facing its steepest downturn in two decades, with nationwide admissions plunging to just 40.7 million in the first ...
Hosted on MSN

JP Morgan Downgrades Replimune Group (REPL)

Fintel reports that on September 19, 2025, JP Morgan downgraded their outlook for Replimune Group (NasdaqGS:REPL) from Neutral to Underweight. Analyst Price Forecast Suggests 110.57% Upside As of ...
Krebs on Security

Self-Replicating Worm Hits 180+ Software Packages

At least 187 code packages made available through the JavaScript repository NPM have been infected with a self-replicating worm that steals credentials from developers and publishes those secrets on ...